Cargando…
GSTP1 and GSTO1 single nucleotide polymorphisms and the response of bladder cancer patients to intravesical chemotherapy
SNPs may restrict cell detoxification activity and be a potential risk factor for cancer chemosensitivity. We evaluated the predictive value of these polymorphisms on the sensitivity of bladder cancer patients to epirubicin and mitomycin chemotherapy instillation as well as their toxicities. SNPs we...
Autores principales: | Deng, Xiaheng, Yang, Xiao, Cheng, Yidong, Liu, Xuzhong, Li, Xiao, Zhao, Ruizhe, Qin, Chao, Lu, Qiang, Yin, Changjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4564850/ https://www.ncbi.nlm.nih.gov/pubmed/26354850 http://dx.doi.org/10.1038/srep14000 |
Ejemplares similares
-
AB143. Pharmacogenetic association between XRCC1 polymorphisms and improved outcomes in bladder cancer patients following intravesical instillation of epirubicin
por: Li, Pengchao, et al.
Publicado: (2016) -
GSTO1, GSTO2 and ACE2 Polymorphisms Modify Susceptibility to Developing COVID-19
por: Djukic, Tatjana, et al.
Publicado: (2022) -
The Polymorphisms in GSTO Genes (GSTO1 rs4925, GSTO2 rs156697, and GSTO2 rs2297235) Affect the Risk for Testicular Germ Cell Tumor Development: A Pilot Study
por: Petrovic, Milos, et al.
Publicado: (2023) -
Association of GSTO1 and GSTO2 Polymorphism with Risk of End-Stage Renal Disease Development and Patient Survival
por: Cimbaljevic, Slavica, et al.
Publicado: (2016) -
Association between NFKB1 −94ins/del ATTG Promoter Polymorphism and Cancer Susceptibility: An Updated Meta-Analysis
por: Yang, Xiao, et al.
Publicado: (2014)